AxisBiotix has launched a probiotic food supplement aimed at alleviating the symptoms of psoriasis in the UK and the US.
Created by researchers at SkinBioTherapeutic, the new supplement contains “specifically selected bacteria” aimed at relieving inflammation caused by psoriasis.
AxisBiotix-Ps is sold in powder form and can be dissolved in cold beverages or added to food on a daily basis. It does not contain steroids.
Stuart Ashman, CEO of SkinBioTherapeutics, said: “We are delighted that…we can make AxisBiotix-Ps available to anyone in the US and the UK. Psoriasis can be an excruciating condition, with many suffering with it for decades. After years of scientific research, we now want to support the psoriatic community with a new approach in addressing their symptoms, in the form of a non-prescription-based food supplement, which is straightforward to add to the daily routine.”
He continued: “Our consumer study resulted in excellent outcomes in terms of subsidence of redness, itchiness and flakiness among the majority of our participants, and we hope that many more will find relief by using our product”.
Each sachet of AxisBiotix-Ps costs $2.00 in the US and £1.50 in the UK. The product is sold in boxes of 28 sachets and consumers can subscribe on a four-weekly or eight-weekly plan.
© FoodBev Media Ltd 2021
World Beverage Innovation Awards – NOW OPEN FOR ENTRIES!
The awards celebrate excellence and innovation across the global beverage industry.
Don’t miss out on having your innovations recognised on a global scale.
Deadline for entries 23 July – enter now!
Don’t get left behind
Start your free Foodbev magazine trial today and join thousands of fellow industry professionals in receiving food and drink trends direct to our business.
Click here to start your free trial